-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Elicio Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2020 to Q3 2025.
- Elicio Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.6 USD/shares, a 56.8% increase year-over-year.
- Elicio Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was -3 USD/shares, a 117% decline year-over-year.
- Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -4.25 USD/shares, a 38.9% increase from 2023.
- Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -6.96 USD/shares, a 92.2% increase from 2022.
- Elicio Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -89.3 USD/shares, a 4525% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)